Full-Time

Senior Firmware Engineer

iota Biosciences

iota Biosciences

51-200 employees

Ultrasound-powered, implantable diagnostic and therapeutic devices

Compensation Overview

$130k - $180k/yr

+ Bonus + LTIP

Alameda, CA, USA

In Person

Category
Software Engineering (1)
Required Skills
C/C++
DevOps
Requirements
  • B.S. in computer science, electrical engineering, or related technical field, with 6+ years industry work experience programming in C/C++
  • OR M.S. in computer science, electrical engineering, or related technical field, with 4+ years industry work experience programming in C/C++
  • Experience in Real-time OS (RTOS) for embedded platforms
  • Experience in wireless communication protocols like Bluetooth low energy (BLE)
Responsibilities
  • Design, develop, test, and optimize embedded software for iota's devices across the entire product lifecycle.
  • Optimize RF/BLE power delivery and control system implemented on an embedded platform. Use modern software techniques to support multiple products while maximizing software reuse.
  • Collaborate with software engineers to develop the "big data" infrastructure for efficiently sending all required data from the embedded processor to the application software, cloud backend, as well as retrieving any configuration data and messages from the backend.
  • Own the process of verifying embedded software to medical regulatory standards while maintaining an industry-leading development pace.
  • Improve team software development processes and infrastructure including DevOps activities.
Desired Qualifications
  • Experience with test automation tools (e.g., Jenkins) and modern software test/deployment methodologies.
  • Comfortable working in a python environment for tests and prototyping.
  • Substantial prior experience with ISO 13485 (QMS), ISO 14971 (risk management) and/or IEC 62304 (medical device software)

iota Biosciences develops ultra-small, implantable bioelectronic devices that monitor and modulate bodily signals from inside the body. Their neural dust concept uses ultrasound to power these tiny implants and to carry data, enabling millimeter-scale devices implanted with minimal invasiveness. This approach eliminates bulky batteries and wired connections, allowing deep-tissue sensing and precise neuromodulation for real-time, closed-loop therapies. Astellas acquired Iota in 2020 to accelerate clinical development across areas like bladder disorders, autoimmune diseases, cancer, and neurological conditions.

Company Size

51-200

Company Stage

Acquired

Total Funding

$142.5M

Headquarters

Berkeley, California

Founded

2017

Your Connections

People at iota Biosciences who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA approved IDE in 2024 for underactive bladder early feasibility study.
  • Staged EFS enrolls up to 10 participants after initial three-patient safety.
  • Four open positions signal active hiring for bladder therapies expansion.

What critics are saying

  • Caltech Neural Dust 2.0 erodes ultrasound efficiency advantage within 12-24 months.
  • FDA rejects EFS expansion beyond 10 participants due to Stage 1 safety in 6-12 months.
  • Astellas diverts funding to Propella gene therapy, stalling Iota milestones in 12-18 months.

What makes iota Biosciences unique

  • Iota's neural dust uses ultrasound for wireless power and communication in millimeter implants.
  • Devices enable minimally invasive deep-tissue biosensing and nerve stimulation.
  • Founders Carmena and Maharbiz pioneered neural dust from UC Berkeley in 2017.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Onsite Gym

Paid Vacation

Paid Parental Leave

Flexible Work Hours

401(k) Retirement Plan

Annual Bonus Plan

Long Term Incentive Plan (LTIP)

Stock Options

Family Planning Benefits

Fertility Treatment Support

Conference Attendance Budget

Professional Development Budget

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Growth & Insights

Headcount

6 month growth

29%

1 year growth

29%

2 year growth

33%